Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, 5020 Salzburg, Austria.
Department of Internal Medicine I, Division of Gastroenterology, Hepathology, Nephrology, Metabolism and Diabetology, Paracelsus Medical University of Salzburg, 5020 Salzburg, Austria.
Int J Mol Sci. 2024 May 20;25(10):5568. doi: 10.3390/ijms25105568.
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression by binding to target messenger RNAs (mRNAs). miRNAs have been implicated in a variety of cardiovascular and neurological diseases, such as myocardial infarction, cardiomyopathies of various geneses, rhythmological diseases, neurodegenerative illnesses and strokes. Numerous studies have focused on the expression of miRNA patterns with respect to atrial fibrillation (AF) or acute ischemic stroke (AIS) However, only a few studies have addressed the expression pattern of miRNAs in patients with AF and AIS in order to provide not only preventive information but also to identify therapeutic potentials. Therefore, the aim of this review is to summarize 18 existing manuscripts that have dealt with this combined topic of AF and associated AIS in detail and to shed light on the most frequently mentioned miRNAs-1, -19, -21, -145 and -146 with regard to their molecular mechanisms and targets on both the heart and the brain. From this, possible diagnostic and therapeutic consequences for the future could be derived.
微小 RNA(miRNAs)是一类通过与靶信使 RNA(mRNA)结合来调节基因表达的小非编码 RNA 分子。miRNAs 与多种心血管和神经系统疾病有关,如心肌梗死、各种病因的心肌病、节律紊乱疾病、神经退行性疾病和中风。许多研究都集中在 miRNA 模式的表达上,涉及心房颤动(AF)或急性缺血性中风(AIS)。然而,只有少数研究探讨了 AF 和 AIS 患者中 miRNA 的表达模式,以便不仅提供预防信息,还能确定治疗潜力。因此,本综述的目的是详细总结 18 篇已经涉及 AF 和相关 AIS 这一联合主题的现有文献,并阐明最常提到的 miRNAs-1、-19、-21、-145 和 -146 在心脏和大脑上的分子机制和靶标。由此,可以得出未来可能的诊断和治疗结果。